MENA: BioCryst Partners with NewBridge Pharma to Market ORLADEYO
The Ministry of Health and Prevention (MOHAP) in the United Arab Emirates (UAE) has granted BioCryst Pharmaceuticals marketing authorization for their oral medication ORLADEYO® (berotralstat) to help prevent frequent hereditary angioedema (HAE) attacks in patients 12...
Soin Therapeutics receives FDA Orphan Drug Status Grant
The US FDA (Food and Drug Administration) has granted Ohio-based pharmaceutical company Soin Therapeutics orphan drug status for low dose naltrexone (LDN) for the treatment of complex regional pain syndrome (CRPS). Complex Regional Pain Syndrome is characterized by...
Novavax Begins Australian Influenza/COVID-19 Vaccine Trial
American biotech company Novavax announced that it will begin an early-staged trial for a combined influenza/COVID-19 vaccine. The trial will be conducted in Australia and will include 640 adults (between 50 and 70 years of age) and who have either been previously...
UK Study Shows COVID-19 Vaccines Reduce Risk of Long COVID
A UK study has shown that the risk of developing long COVID, as well as severe illness caused by COVID-19, is greatly reduced in a person who is fully vaccinated. Published by the Lancet Infectious Diseases Journal, the study indicates that those who have received...
FDA Asks Eli Lilly, Pfizer, and AbbVie to List JAK Warnings
The US FDA (Food and Drug Administration) has asked Eli Lilly & Co, Pfizer, and AbbVie, to inform consumers about potential risks relating to their high-profile Janus kinase (JAK) inhibitor medications. The FDA has ordered label warnings that list a heightened...
78 Million People With Dementia by 2030, WHO Predicts
Dubbed a global health concern, The WHO (World Health Organization) has projected that the number of people living with dementia will increase to 78 million by the year 2030 and will cost the global economy $1.3 trillion p/a. Currently, there are over 55 million...